Listen to the podcast below: Open Media SPAC Deal Allurion Technologies is taking a big step toward global commercialization of its unique weight-loss program by going public through a combination wit
Allurion Technologies is taking a big step toward global commercialization of its unique weight-loss program by going public through a combination with Compute Health Acquisition Corporation. Compute
Allurion Technologies Inc. is ramping up its leadership team, supporting efforts to enter new markets with its Elipse Balloon , a nonsurgical gastric balloon intended to treat patients with obesity
The highly competitive global market for minimally invasive weight loss (bariatric) devices is predicted to rise from $137m in 2016 to $290m by 2021, a CAGR of 16%. This is driven in large part by the